1. 3221 Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice. (September 2015) Authors: Krekeler, G.; Neuhof, A.; Dreyling, M.; Hess, G.; Kalanovic, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors. Issue 11 (4th August 2014) Authors: Fink, S. E. K.; Gandhi, M. K.; Nourse, J. P.; Keane, C.; Jones, K.; Crooks, P.; Jöhrens, K.; Korfel, A.; Schmidt, H.; Neumann, S.; Tiede, A.; Jäger, U.; Dührsen, U.; Neuhaus, R.; Dreyling, M.; Borchert, K.; Südhoff, T.; Riess, H.; Anagnostopoulos, I.; Trappe, R. U. Journal: American journal of transplantation Issue: Volume 14:Issue 11(2014:Nov.) Page Start: 2577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Wang, M.; Belada, D.; Cheah, C.; Chu, M.P.; Dreyling, M.; Flinn, I.; Fogliatto, L.; Goy, A.; Inwards, D.; Jurczak, W.; Mayer, J.; Re, F.; Robak, T.; Spurgeon, S.; Yoon, S.S.; Zinzani, P.L.; Yin, M.; Chen, T.; Kahl, B. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 554 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ANTI‐INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE SIGNIFICANTLY REDUCES THE RATE OF INFECTIONS AND THERAPY‐ASSOCIATED DEATHS IN ELDERLY PATIENTS WITH DLBCL UNDERGOING R‐CHOP IMMUNOCHEMOTHERAPY. (June 2017) Authors: Murawski, N.; Amam, J.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A.; Neubauer, A.; Held, G.; Truemper, L.; Dreyling, M.; Kanz, L.; Hallek, M.; Schmitz, N.; Heintges, T.; Koelbel, C.; Poeschel, V.; Pfreundschuh, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION‐FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Zoellner, A.; Unterhalt, M.; Stilgenbauer, S.; Hübel, K.; Thieblemont, C.; Metzner, B.; Kluin‐Nelemans, H.; Hiddemann, W.; Dreyling, M.; Hoster, E. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bruton's tyrosine kinase inhibitors in B-cell lymphoma: current experience and future perspectives. (3rd August 2017) Authors: Seiler, T.; Dreyling, M. Journal: Expert opinion on investigational drugs Issue: Volume 26:Number 8(2017) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY. (June 2017) Authors: Tam, C.S.; Roberts, A.W.; Anderson, M.; Dawson, S.; Hicks, R.; Burbury, K.; Turner, G.; Di Iulio, J.; Bressel, M.; Westerman, D.; Agarwal, R.; Pott, C.; Dreyling, M.; Dawson, M.; Seymour, J.F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. COPANLISIB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA (CHRONOS‐1). (June 2017) Authors: Dreyling, M.; Santoro, A.; Mollica, L.; Leppä, S.; Follows, G.A.; Lenz, G.; Kim, W.; Nagler, A.; Panayiotidis, P.; Demeter, J.; Özcan, M.; Kosinova, M.; Bouabdallah, K.; Morschhauser, F.; Stevens, D.A.; Trevarthen, D.; Giurescu, M.; Liu, L.; Koechert, K.; Peña, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. COPANLISIB TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA. (12th June 2019) Authors: Panayiotidis, P.; Kellner, A.; Follows, G.A.; Mollica, L.; Nagler, A.; Özcan, M.; Santoro, A.; Hiemeyer, F.; Liu, L.; Garcia‐Vargas, J.; Childs, B.H.; Zinzani, P.L.; Dreyling, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. (12th June 2019) Authors: Dreyling, M.; Santoro, A.; Leppä, S.; Demeter, J.; Follows, G.A.; Lenz, G.; Kim, W.S.; Mollica, L.; Nagler, A.; Phipps Diong, C.; Provencio, M.; Magagnoli, M.; Munoz, J.; Hiemeyer, F.; Liu, L.; Miriyala, A.; Rodrigues, L.; Garcia‐Vargas, J.; Childs, B.H.; Zinzani, P.L. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗